Home About Us Writing a Scientific Article Author's Instruction Contact us
 

MERIT RESEARCH JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (MRJPPS) (ISSN: 2408-7025)

 
 

/  /    MRJPPS Home    /   /    About MRJPPS   /  /    Submit Manuscripts     /  /      Call For Articles      / /     Editorial Board     / /    Archive     / /    Author's Guide  /  /

 
 


September 2013 Vol. 1 No. 1

Other viewing option


Abstract
• Full text
Reprint (PDF) (136KB)


Search Pubmed for articles by:
 

Zhang M
Yiling Wu

Other links:
PubMed Citation
Related articles in PubMed

 

 

Merit Research Journal of Pharmacy and Pharmaceutical Sciences Vol. 1(1) pp. 001-007 September, 2013 

Copyright © 2013 Merit Research Journals

Full Length Research Paper

The antioxidant effect of picrosideand the optimizing of therapeutic dose and time window in cerebral ischemic injury in rats

 
 
 

Meizeng Zhang1*, Pang Fangfang1, Rui Zhang2, Li Zhao1 and Yiling Wu3

 

1Department of Neurology, Affiliated Hospital of Qingdao University Medical College, Qingdao 266003, China
2Department of ICU, Affiliated Hospital of Qingdao University Medical College, Qingdao 266003, China
3Department of Rehabilitation, Affiliated Hospital of Qingdao University Medical College, Qingdao 266003, China

*Corresponding Author's E-mail: zmzcmd@163.com; Tel: +8618661808039

Accepted August 26, 2013

 

Abstract

 

To optimize the antioxidant effect and the best therapeutic dose and time window of picrosidein cerebral ischemic injury in rats by orthogonal test. The forebrain ischemia models were established by bilateral common carotid artery occlusion (BCCAO) methods. The successful rat models were randomly divided into 16 groups according to orthogonal experimental design of [L16(45)] and treated by injecting picrosideintraperitoneally with different doses at various times. The concentrations of malondialdehyde (MDA), nitric oxide (NO) and hydrogen per oxide (H2O2) in serum and brain tissue were respectively determined by thiobarbituric acid assay, nitratase reductase assay and chemiluminescence’s immunoassay. The optimized compositions of the therapeutic dose and time window of picrosidein cerebral ischemic injury were (1) ischemia 1.5h with 10mg/kg, 1.5h with 20mg/kg and 1.5h with 10mg/kg body weight according to the expressions of MDA, NO and H2O2 in serum respectively, (2) ischemia 1.5h with 10mg/kg, 1.5h with 20mg/kg and 1.5h with 20mg/kg body weight according to the expressions of MDA, NO and H2O2 in brain tissue respectively. Conclusion On the basis of the principle of the minimization of medication dose and maximization of therapeutic time window, the optimized composition of the therapeutic dose and time window in cerebral ischemic injury was injecting picroside intraperitoneally with 10-20mg/kg body weight at ischemia 1.5h.

Keywords: picroside
, cerebral ischemia, therapeutic dose, time window, MDA, NO, H2O2, rats

 

 
 
   
   
   
   
   
   
   
   
   
   
   
 
 
 
 
 
 
 
 
   
 
                         

Merit Research Journals© 2016 || Advertisement | Privacy policy.